María del Mar Gutiérrez-Lobón
María del Mar Gutiérrez-Lobón has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Araceli Nuñez Ventura
Pharmacoepidemiology and Pharmacovigilance Division, Medicines for Human Use Department, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
2 shared publications - Cristina Fernández-Fernández
Risk Identification Unit, Division of Pharmacovigilance, Medicines for Human Use Department Spanish Agency of Medicines and Medical Devices (AEMPS) Madrid Spain
2 shared publications - Nuria Sols Cueto
Agencia Española de Medicamentos y Productos Sanitarios
2 shared publications - Eugène P. van Puijenbroek
Groningen Research Institute of Pharmacy, Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands
1 shared publication - Florence van Hunsel
Netherlands Pharmacovigilance Centre Lareb, MH’s-Hertogenbosch, The Netherlands
1 shared publication - Joep Scholl
Netherlands Pharmacovigilance Centre Lareb, MH’s-Hertogenbosch, The Netherlands
1 shared publication
Latest Publications
- 21 September 2026
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 82 (10) , 254
Masking effect in the Spanish spontaneous reporting database FEDRA
- 21 September 2026
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 82 (10) , 254
Masking effect in the Spanish spontaneous reporting database FEDRA
- Open Access
- 7 January 2026
- Published by Springer Nature in Drug Safety
- Vol. 49 (5) , 581-590
Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases
Background The COVID-19 mass vaccination led to a substantial increase in spontaneous reports submitted to pharmacovigilance (PV) databases, potentially introducing masking effects that could conceal safety signals. Objectives To examine the masking effect of COVID-19 vaccines on disproportionality analyses and to compare two unmasking interventions in the Dutch (Lareb database) and Spanish (Farmacovigilancia Española, Datos de Reacciones Adversas, FEDRA) national PV databases: removal of all drug–event combinations (DEC) involving a COVID-19 vaccine versus excluding influential outliers DECs only. Methods The masking effect was explored retrospectively on the basis of the number of signals of disproportionate reporting (SDR). DECs involving a COVID-19 vaccine were excluded using crude and outlier techniques, and reporting odds ratios were recalculated. Subsets of important medical events (IME) were analysed in both databases. Results Both crude and influential outlier removal methods led to reductions in the number of reports, DECs and SDRs. Both in the Lareb database and FEDRA, crude removal excluded 2.1% of DECs, while the outlier method excluded 0.1%. Crude removal had a greater impact on SDRs, reducing them by 9.8% in the Lareb database and 3.9% in FEDRA, compared with 5.7% and 1.1% with the outlier method. In the Lareb database, 1301 SDRs (20 IME-related) were unmasked using crude removal, and 1942 (95 IME-related) with the outlier method. FEDRA showed 1453 and 1226 SDRs unmasked, including 41 and 70 IME-related. Conclusions COVID-19 vaccines caused substantial masking in both databases. Both strategies effectively revealed new SDRs, though their impact varied. The choice of approach should be tailored to the database context.
- 7 January 2026
- Published by Springer Nature in Drug Safety
- Vol. 49 (5) , 581-590
Open AccessEvaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases
Background The COVID-19 mass vaccination led to a substantial increase in spontaneous reports submitted to pharmacovigilance (PV) databases, potentially introducing masking effects that could conceal safety signals. Objectives To examine the masking effect of COVID-19 vaccines on disproportionality analyses and to compare two unmasking interventions in the Dutch (Lareb database) and Spanish (Farmacovigilancia Española, Datos de Reacciones Adversas, FEDRA) national PV databases: removal of all drug–event combinations (DEC) involving a COVID-19 vaccine versus excluding influential outliers DECs only. Methods The masking effect was explored retrospectively on the basis of the number of signals of disproportionate reporting (SDR). DECs involving a COVID-19 vaccine were excluded using crude and outlier techniques, and reporting odds ratios were recalculated. Subsets of important medical events (IME) were analysed in both databases. Results Both crude and influential outlier removal methods led to reductions in the number of reports, DECs and SDRs. Both in the Lareb database and FEDRA, crude removal excluded 2.1% of DECs, while the outlier method excluded 0.1%. Crude removal had a greater impact on SDRs, reducing them by 9.8% in the Lareb database and 3.9% in FEDRA, compared with 5.7% and 1.1% with the outlier method. In the Lareb database, 1301 SDRs (20 IME-related) were unmasked using crude removal, and 1942 (95 IME-related) with the outlier method. FEDRA showed 1453 and 1226 SDRs unmasked, including 41 and 70 IME-related. Conclusions COVID-19 vaccines caused substantial masking in both databases. Both strategies effectively revealed new SDRs, though their impact varied. The choice of approach should be tailored to the database context.